In Brief | Published:

VASCULITIS

Tocilizumab improves quality of life in GCA

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Strand, V. et al. Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial. Arthritis Res. Ther. 21, 64 (2019)

    Download references

    Author information

    Correspondence to Joanna Collison.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark